The type 2 inflammatory response favors recognition of tumor antigens by IgE in breast cancer.
Espiridión Ramos-MartínezFrancisco Javier García-VazquezRamcés Falfan-ValenciaJorge Rojas-SerranoAna Alfaro-CruzMarcela Pérez-VillaseñorGerardo Aristi-UristaJesús Pérez-HernándezRosario López-VancellAndrea Velasco-MedinaGuillermo Velázquez-SámanoPublished in: Cancer reports (Hoboken, N.J.) (2024)
Purified IgE antibodies specifically recognize tumor cells in breast ductal carcinoma.